Dec 14, 2018 12:00PM
Dec 3, 2018 09:15PM
Dec 2, 2018 10:30AM
Nov 27, 2018 08:00AM
Nov 1, 2018 12:00PM
Oct 25, 2018 08:00AM
Oct 22, 2018 08:55AM New Data Added to TRINTELLIX® (vortioxetine) Labeling Demonstrated Superiority Over Escitalopram in Improving SSRI-Induced Sexual Dysfunction in Patients with Major Depressive Disorder
Oct 19, 2018 08:00AM
Oct 1, 2018 06:48AM
Oct 1, 2018 06:45AM
Sep 25, 2018 08:32AM
Sep 21, 2018 09:30AM
Jul 25, 2018 08:00AM
Jul 19, 2018 01:00AM New Phase 3 Data Show Investigational Subcutaneous Formulation of Vedolizumab Meets Primary Endpoint in Achieving Clinical Remission at Week 52 in Patients with Moderately to Severely Active Ulcerativ
Jul 11, 2018 08:00AM
May 17, 2018 12:00PM
May 2, 2018 05:36PM
Apr 25, 2018 01:03AM
Mar 23, 2018 02:00PM
Mar 22, 2018 08:00AM
Jan 29, 2018 08:00AM Takeda’s Zika Vaccine Candidate Receives U.S. FDA Fast Track Designation
Jan 22, 2018 08:00AM
Jan 5, 2018 05:54AM
Jan 5, 2018 02:00AM
Jan 5, 2018 01:22AM
Dec 10, 2017 08:00AM
Dec 10, 2017 08:00AM
Nov 14, 2017 10:00AM Takeda Receives Positive CHMP Opinion for ADCETRIS® (brentuximab vedotin) for CD30-Positive Cutaneous T-Cell Lymphoma
Nov 1, 2017 12:00PM
Oct 17, 2017 07:00AM
Oct 16, 2017 02:45AM
Oct 3, 2017 08:08AM
Oct 3, 2017 08:00AM
Oct 3, 2017 08:00AM
Sep 27, 2017 06:00PM Takeda to Feature ALUNBRIG™ (brigatinib) Data from Pivotal Phase 2 ALTA Trial at 18th World Conference on Lung Cancer
Jul 25, 2017 09:00AM
Jun 26, 2017 06:45AM
Jun 23, 2017 03:00AM
Jun 7, 2017 08:01AM
Jun 7, 2017 08:00AM
May 24, 2017 08:00AM
May 8, 2017 08:00AM Takeda Announces Publication of ALUNBRIG™ (brigatinib) Pivotal Phase 2 ALTA Clinical Trial Data in Journal of Clinical Oncology
Apr 28, 2017 06:13PM
Feb 17, 2017 03:10AM
Feb 1, 2017 01:00AM
Jan 30, 2017 06:00PM
Jan 19, 2017 03:01PM
Jan 19, 2017 03:00PM
Jan 9, 2017 08:02AM Takeda to Acquire ARIAD Pharma (ARIA) for $5.2B
Jan 9, 2017 08:00AM

324,034 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All